K. S. Eremin
K. S. Eremin has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Anastasia V. Galina
National Medical Research Centre for Oncology Rostov-on-Don, Russian Federation
2 shared publications - Anna A. Shulga
National Medical Research Centre for Oncology Rostov-on-Don, Russian Federation
2 shared publications - Anna S. Goncharova
National Medical Research Centre for Oncology Rostov-on-Don, Russian Federation
2 shared publications - Anton Grigor'EVich Milakin
National Medical Research Centre for Oncology
2 shared publications - Darya V. Khodakova
National Medical Research Centre for Oncology Rostov-on-Don, Russian Federation
2 shared publications - Igor V. Golovinov
National Medical Research Centre for Oncology Rostov-on-Don, Russian Federation
2 shared publications
Latest Publications
- 15 June 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 6,p. 108-112
Congenital intrathoracic accessory spleen: a case report
Accessory spleen is a rare anomaly occurring in approximately 10% of people. Most often, accessory spleen can be located in spleen gate. However, localization in parenchymal abdominal organs, retroperitoneal space, pelvis and chest is also possible. Congenital accessory spleen is extremely rare, and only several cases are described in the literature. Diagnosis causes some difficulties. CT-based differentiation with malignant tumor is difficult. We present a 72-year-old patient with congenital intrathoracic accessory spleen.
- 15 June 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 6,p. 108-112
Congenital intrathoracic accessory spleen: a case report
Accessory spleen is a rare anomaly occurring in approximately 10% of people. Most often, accessory spleen can be located in spleen gate. However, localization in parenchymal abdominal organs, retroperitoneal space, pelvis and chest is also possible. Congenital accessory spleen is extremely rare, and only several cases are described in the literature. Diagnosis causes some difficulties. CT-based differentiation with malignant tumor is difficult. We present a 72-year-old patient with congenital intrathoracic accessory spleen.
- 17 December 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (4) , 26-35
Cytostatic effect of ricobendazole on primary cultures of soft tissue sarcomas in vitro
Soft tissue sarcomas (STS) are often resistant to treatment. The search for new antitumor compounds against STS remains an urgent task. Purpose of the study. To assess the sensitivity of primary STS cultures of various histological subtypes to albendazole sulfoxide (ricobendazole) and doxorubicin, the primary metabolite of albendazole. Materials and methods . STS tumor samples were used. The enzymatic dissociation method was used using 300 units/ml collagenase I (Thermo Fisher Scientific, USA). Ricasol® (NITA-PHARM, Russia) and Doxorubicin-LENS® (VEROPHARM, Russia) were used as test substances. Sensitivity to ricobendazole and doxorubicin was tested using the MTT test. The cultures were seeded in a 96‑well plate at 7,000 cells in DMEM medium with 10 % FSC added. After 24 h, the medium was replaced with PPS with ricobendazole in a series of two-fold dilutions from 35.5 μmol/l to 0.0347 μmol/l or doxorubicin from 10 μmol/l to 0.009 μmol/l. After 72 hours of incubation, the MTT test was performed. The cells were seeded in a 24‑well plate and cultured in PPS with 2 μmol/l ricabendazole for 72 h. Hoechst 33342 dye (Life Technologies, USA) was added to the culture at a concentration of 1 μg/ml, and photographs were taken using a LionHeart FX digital automatic microscope (BioTek Instruments Inc., USA). Results. Four primary sarcoma cultures were obtained: SAR‑1, SAR‑2, SAR‑3, and SAR‑4. SAR-1 and SAR-4. Cultures demonstrated the most rapid growth, with doubling times of 38 and 27 hours, respectively. The slowest proliferation was observed in the SAR-2 culture (doubling time 156 hours), while SAR-3 showed a doubling time of 45 hours. According to the MTT assay, the IC50 values for ricobendazole were 4.54 ± 1.2 μmol/L for SAR-1, 3.31 ± 0.7 μmol/L for SAR-3, and 1.51 ± 0.2 μmol/L for SAR-4, whereas the slowly dividing SAR-2 culture proved to be insensitive to ricobendazole. The cytostatic activity of doxorubicin was higher than that of ricobendazole. The SAR‑2 culture was the least sensitive (IC50 could not be determined), and SAR‑4 (IC50 SAR‑4 = 0.16 ± 0.01 μmol/l) was the most sensitive to the action of doxorubicin. The IC50 value of SAR‑1 = 0.64 ± 0.02 μmol/l and IC50 SAR‑3 = 1.8 ± 0.1 μmol/l. The effect of ricobendazole caused pronounced disturbances in the nuclei of SAR‑1 and SAR‑4 cultures, in SAR‑2 and SAR‑3 they were less pronounced. Conclusion. Ricobenzale had a cytostatic effect on primary STS cultures characterized by rapid cell growth, but the activity was lower than that of doxorubicin. Changes in the morphology of cells and nuclei indicated probable disturbances in the functioning of the spindle and cytoskeleton occurring under the action of this compound. Of particular interest for further research is the combination of ricobendazole with taxanes and other tubulin inhibitors.
- 17 December 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (4) , 26-35
Cytostatic effect of ricobendazole on primary cultures of soft tissue sarcomas in vitro
Soft tissue sarcomas (STS) are often resistant to treatment. The search for new antitumor compounds against STS remains an urgent task. Purpose of the study. To assess the sensitivity of primary STS cultures of various histological subtypes to albendazole sulfoxide (ricobendazole) and doxorubicin, the primary metabolite of albendazole. Materials and methods . STS tumor samples were used. The enzymatic dissociation method was used using 300 units/ml collagenase I (Thermo Fisher Scientific, USA). Ricasol® (NITA-PHARM, Russia) and Doxorubicin-LENS® (VEROPHARM, Russia) were used as test substances. Sensitivity to ricobendazole and doxorubicin was tested using the MTT test. The cultures were seeded in a 96‑well plate at 7,000 cells in DMEM medium with 10 % FSC added. After 24 h, the medium was replaced with PPS with ricobendazole in a series of two-fold dilutions from 35.5 μmol/l to 0.0347 μmol/l or doxorubicin from 10 μmol/l to 0.009 μmol/l. After 72 hours of incubation, the MTT test was performed. The cells were seeded in a 24‑well plate and cultured in PPS with 2 μmol/l ricabendazole for 72 h. Hoechst 33342 dye (Life Technologies, USA) was added to the culture at a concentration of 1 μg/ml, and photographs were taken using a LionHeart FX digital automatic microscope (BioTek Instruments Inc., USA). Results. Four primary sarcoma cultures were obtained: SAR‑1, SAR‑2, SAR‑3, and SAR‑4. SAR-1 and SAR-4. Cultures demonstrated the most rapid growth, with doubling times of 38 and 27 hours, respectively. The slowest proliferation was observed in the SAR-2 culture (doubling time 156 hours), while SAR-3 showed a doubling time of 45 hours. According to the MTT assay, the IC50 values for ricobendazole were 4.54 ± 1.2 μmol/L for SAR-1, 3.31 ± 0.7 μmol/L for SAR-3, and 1.51 ± 0.2 μmol/L for SAR-4, whereas the slowly dividing SAR-2 culture proved to be insensitive to ricobendazole. The cytostatic activity of doxorubicin was higher than that of ricobendazole. The SAR‑2 culture was the least sensitive (IC50 could not be determined), and SAR‑4 (IC50 SAR‑4 = 0.16 ± 0.01 μmol/l) was the most sensitive to the action of doxorubicin. The IC50 value of SAR‑1 = 0.64 ± 0.02 μmol/l and IC50 SAR‑3 = 1.8 ± 0.1 μmol/l. The effect of ricobendazole caused pronounced disturbances in the nuclei of SAR‑1 and SAR‑4 cultures, in SAR‑2 and SAR‑3 they were less pronounced. Conclusion. Ricobenzale had a cytostatic effect on primary STS cultures characterized by rapid cell growth, but the activity was lower than that of doxorubicin. Changes in the morphology of cells and nuclei indicated probable disturbances in the functioning of the spindle and cytoskeleton occurring under the action of this compound. Of particular interest for further research is the combination of ricobendazole with taxanes and other tubulin inhibitors.
- Open Access
- 22 May 2025
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 10 (2) , 103-111
Evaluation of Clinically Relevant Markers in a Patient-Derived Xenograft Model of Triple-Negative Breast Cancer
Objective: To evaluate a correlation of clinically relevant markers between a patient-derived xenograft (PDX) model and triple-negative breast cancer (TNBC).Materials and methods: For the PDX model of TNBC, we used tumor tissue from patient E. who presented with right-sided breast cancer at the National Medical Research Centre for Oncology (Rostov-on-Don, Russian Federation). The tumor fragments were subcutaneously implanted into BALB/c nude mice; thus, the first-generation xenograft was obtained. The xenogeneic model was studied on the fourth generation. The PDX model tissues and the patient’s tumor were analyzed by histological, immunohistochemical, and molecular genetic methods. For the immunohistochemical study we used antibodies against ER (estrogen receptor), PR (progesterone receptor), HER2/neu (human epidermal growth factor receptor 2), and Ki-67 (proliferation marker). Molecular genetic testing of the BRCA1 and BRCA2 genes was performed using real-time polymerase chain reaction.Results: The histological examination demonstrated a correlation between the histotype of the original tumor tissue and the xenograft. Immunohistochemical analysis of the tumor samples revealed no expression of ER, PR, and HER2 markers. We identified 80% of Ki-67-expressing cells in the patient’s tumor and 90% in the xenograft. Furthermore, no mutations in the BRCA1 and BRCA2 genes were found in the patient’s tumor and the corresponding xenograft.Conclusions: We evaluated clinically relevant markers in the PDX model of TNBC and found the correlation with the corresponding characteristics of the patient’s tumor. Thus, we generated the PDX model that can be utilized for both fundamental and preclinical research in oncology, eg, to study antitumor efficacy of novel drugs in TNBC and identify mechanisms of sensitivity or resistance to various therapeutic interventions.
- 22 May 2025
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 10 (2) , 103-111
Open AccessEvaluation of Clinically Relevant Markers in a Patient-Derived Xenograft Model of Triple-Negative Breast Cancer
Objective: To evaluate a correlation of clinically relevant markers between a patient-derived xenograft (PDX) model and triple-negative breast cancer (TNBC).Materials and methods: For the PDX model of TNBC, we used tumor tissue from patient E. who presented with right-sided breast cancer at the National Medical Research Centre for Oncology (Rostov-on-Don, Russian Federation). The tumor fragments were subcutaneously implanted into BALB/c nude mice; thus, the first-generation xenograft was obtained. The xenogeneic model was studied on the fourth generation. The PDX model tissues and the patient’s tumor were analyzed by histological, immunohistochemical, and molecular genetic methods. For the immunohistochemical study we used antibodies against ER (estrogen receptor), PR (progesterone receptor), HER2/neu (human epidermal growth factor receptor 2), and Ki-67 (proliferation marker). Molecular genetic testing of the BRCA1 and BRCA2 genes was performed using real-time polymerase chain reaction.Results: The histological examination demonstrated a correlation between the histotype of the original tumor tissue and the xenograft. Immunohistochemical analysis of the tumor samples revealed no expression of ER, PR, and HER2 markers. We identified 80% of Ki-67-expressing cells in the patient’s tumor and 90% in the xenograft. Furthermore, no mutations in the BRCA1 and BRCA2 genes were found in the patient’s tumor and the corresponding xenograft.Conclusions: We evaluated clinically relevant markers in the PDX model of TNBC and found the correlation with the corresponding characteristics of the patient’s tumor. Thus, we generated the PDX model that can be utilized for both fundamental and preclinical research in oncology, eg, to study antitumor efficacy of novel drugs in TNBC and identify mechanisms of sensitivity or resistance to various therapeutic interventions.
- Open Access
- 31 January 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (1) , 32-40
In vivo microcomputed tomography visualization of a hepatocellular carcinoma orthotopic model using a contrast based on LaF3:Ce(5 %)Tb(15 %) nanoparticles
Purpose of the study. To investigate the effectiveness of a new contrast agent based on LaF3:Ce(5 %)Tb(15 %) nanoparticles on a hepatocellular carcinoma orthotopic model.Materials and methods. The experiment was performed on female BALB/c Nude mice. The subcutaneous model was created by injecting Hep G2 tumor cell culture into the right side of the animals. The orthotopic models were obtained by implanting a fragment of a subcutaneous Hep G2 xenograft into the left lobe of the liver of mice. Colloidal water solutions of LaF3:Ce(5 %)Tb(15 %) nanoparticles were prepared by dispersing the nanoparticle powder in bidistilled water using an ultrasonic tube for 30 minutes. Two samples with different nanoparticle sizes (13 and 60 nm) were administered to mice intravenously in a volume of 200 μl at a concentration of 40 mg/ml. The assessment of changes in radiopacity of the internal organs of animals was carried out at different points in time (before nanoparticle injection, at 5 min, 30 min, 1 h, 2 h, 4 h, 24 h, 48 h, and 7 days after inlection) using microcomputer tomography on a Quantum GX2 device. On the 7th day of the experiment, animals were euthanized by dislocation of the cervical vertebrae, organs (liver and spleen) were collected and fixed in a 10 % solution of neutral formalin. Sections for histological examination and their staining were made according to the standard method.Results. Microcomputer tomography (micro-CT) results indicated accumulation of both contrast samples in the spleen and healthy liver tissue within 5 minutes after intravenous injection, maintaining X-ray contrast for the 7-days. However, no specific accumulation of nanoparticles in the tumor was observed. Histological analysis revealed minimal impact on the liver structure and cells, with a more pronounced effect in the spleen.Conclusion. These findings suggest that LaF3:Ce(5 %)Tb(15 %) metal nanoparticles can be used in in vivo experiments for liver and spleen visualization after further investigation of their long-term effects.
- 31 January 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (1) , 32-40
Open AccessIn vivo microcomputed tomography visualization of a hepatocellular carcinoma orthotopic model using a contrast based on LaF3:Ce(5 %)Tb(15 %) nanoparticles
Purpose of the study. To investigate the effectiveness of a new contrast agent based on LaF3:Ce(5 %)Tb(15 %) nanoparticles on a hepatocellular carcinoma orthotopic model.Materials and methods. The experiment was performed on female BALB/c Nude mice. The subcutaneous model was created by injecting Hep G2 tumor cell culture into the right side of the animals. The orthotopic models were obtained by implanting a fragment of a subcutaneous Hep G2 xenograft into the left lobe of the liver of mice. Colloidal water solutions of LaF3:Ce(5 %)Tb(15 %) nanoparticles were prepared by dispersing the nanoparticle powder in bidistilled water using an ultrasonic tube for 30 minutes. Two samples with different nanoparticle sizes (13 and 60 nm) were administered to mice intravenously in a volume of 200 μl at a concentration of 40 mg/ml. The assessment of changes in radiopacity of the internal organs of animals was carried out at different points in time (before nanoparticle injection, at 5 min, 30 min, 1 h, 2 h, 4 h, 24 h, 48 h, and 7 days after inlection) using microcomputer tomography on a Quantum GX2 device. On the 7th day of the experiment, animals were euthanized by dislocation of the cervical vertebrae, organs (liver and spleen) were collected and fixed in a 10 % solution of neutral formalin. Sections for histological examination and their staining were made according to the standard method.Results. Microcomputer tomography (micro-CT) results indicated accumulation of both contrast samples in the spleen and healthy liver tissue within 5 minutes after intravenous injection, maintaining X-ray contrast for the 7-days. However, no specific accumulation of nanoparticles in the tumor was observed. Histological analysis revealed minimal impact on the liver structure and cells, with a more pronounced effect in the spleen.Conclusion. These findings suggest that LaF3:Ce(5 %)Tb(15 %) metal nanoparticles can be used in in vivo experiments for liver and spleen visualization after further investigation of their long-term effects.
- Open Access
- 21 February 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (1) , 34-41
Metastatic lesions of the uterus, fallopian tubes and ovaries in undifferentiated pleomorphic sarcoma of the left tibia (clinical case)
Undifferentiated pleomorphic osteosarcoma belongs to the group of rarely occurring tumors. Despite the treatment, the disease progresses in 30–40 % of patients with osteosarcomas. The main route of metastasis of bone tissue sarcomas is hematogenous, while lymphogenic spread is observed less frequently. As a rule, secondary metastatic changes occur in the lungs. Less often there is a secondary lesion of the bones of the skeleton and brain. Metastatic lesion of uterus, fallopian tubes and ovaries in malignant undifferentiated pleomorphic sarcoma is extremely rare. Therefore, we found it interesting to describe a clinical case of such a rare metastatic lesion. Patient K. underwent amputation of the left limb at the level of the lower third of the femur for undifferentiated pleomorphic sarcoma of the left tibia in 2019, and 4 courses of adjuvant polychemotherapy were performed. In 20 months after completion of complex treatment of the primary tumor, complaints of lower abdominal pain, increased body temperature up to 37.8 °C in the evenings appeared. According to the results of follow-up examination, a voluminous, multinodular, solid mass of merging character was detected in the pelvis, with total dimensions of up to 11 cm, and a cavitary mass of up to 5 cm was detected in the posterior vault. A trepan-biopsy of the mass in the projection of the right ovary was performed. The morphological picture in the volume of trepan biopsy specimens is characteristic of spindle cell sarcoma. Metastasis of undifferentiated pleomorphic bone sarcoma (malignant fibrous histiocytoma) is most likely. Due to metastatic lesions of the uterus, fallopian tubes, ovaries, omentum, mesentery and serous membrane of the colon loops, peritoneum of the bladder, surgical intervention in the volume of removal of the distal part of the sigmoid colon, rectosigmoid, upper ampullary parts of the rectum, uterus with fallopian tubes and ovaries, appendix was performed. Immunohistochemical study of the postoperative material revealed that the immunophenotype of tumor cells confirmed the morphological picture typical for undifferentiated pleomorphic bone sarcoma. The patient was further prescribed antitumor drug therapy. This clinical case demonstrates a rare, atypical metastasis of undifferentiated pleomorphic osteosarcoma, which allows to expand the knowledge about the flow of malignant diseases of this localization.
- 21 February 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (1) , 34-41
Open AccessMetastatic lesions of the uterus, fallopian tubes and ovaries in undifferentiated pleomorphic sarcoma of the left tibia (clinical case)
Undifferentiated pleomorphic osteosarcoma belongs to the group of rarely occurring tumors. Despite the treatment, the disease progresses in 30–40 % of patients with osteosarcomas. The main route of metastasis of bone tissue sarcomas is hematogenous, while lymphogenic spread is observed less frequently. As a rule, secondary metastatic changes occur in the lungs. Less often there is a secondary lesion of the bones of the skeleton and brain. Metastatic lesion of uterus, fallopian tubes and ovaries in malignant undifferentiated pleomorphic sarcoma is extremely rare. Therefore, we found it interesting to describe a clinical case of such a rare metastatic lesion. Patient K. underwent amputation of the left limb at the level of the lower third of the femur for undifferentiated pleomorphic sarcoma of the left tibia in 2019, and 4 courses of adjuvant polychemotherapy were performed. In 20 months after completion of complex treatment of the primary tumor, complaints of lower abdominal pain, increased body temperature up to 37.8 °C in the evenings appeared. According to the results of follow-up examination, a voluminous, multinodular, solid mass of merging character was detected in the pelvis, with total dimensions of up to 11 cm, and a cavitary mass of up to 5 cm was detected in the posterior vault. A trepan-biopsy of the mass in the projection of the right ovary was performed. The morphological picture in the volume of trepan biopsy specimens is characteristic of spindle cell sarcoma. Metastasis of undifferentiated pleomorphic bone sarcoma (malignant fibrous histiocytoma) is most likely. Due to metastatic lesions of the uterus, fallopian tubes, ovaries, omentum, mesentery and serous membrane of the colon loops, peritoneum of the bladder, surgical intervention in the volume of removal of the distal part of the sigmoid colon, rectosigmoid, upper ampullary parts of the rectum, uterus with fallopian tubes and ovaries, appendix was performed. Immunohistochemical study of the postoperative material revealed that the immunophenotype of tumor cells confirmed the morphological picture typical for undifferentiated pleomorphic bone sarcoma. The patient was further prescribed antitumor drug therapy. This clinical case demonstrates a rare, atypical metastasis of undifferentiated pleomorphic osteosarcoma, which allows to expand the knowledge about the flow of malignant diseases of this localization.
- Open Access
- 21 November 2022
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 3 (4) , 14-25
Practical experience of a lung cancer primary cell culture collection creation at the National Medical Research Centre for Oncology
Purpose of the study. Testing of new chemotherapeutic agents in translational and biology medicine needs studies on immortalized cell lines. However, such models do not always have the biological properties of a tumor in situ, in contrast to primary cell cultures. Primary cultures of lung cancer cells have biological, morphological and molecular characteristics close or identical to tumor cells in vivo. Obtaining collections of primary lung cancer cell lines is an important task in creating various models for preclinical studies.Materials and methods. The materials are represented by postoperative tumor samples obtained from 25 patients with newly diagnosed lung cancer without prior treatment. The following methods were used to obtain primary cultures: enzymatic dissociation in Hanks' solution with the addition of 300 units/ml collagenase I (Thermo Fisher Scientific, USA), enzymatic dissociation using the Brain Tumor Dissoсiation Kit (Miltenyi Biotec, Germany) and 150 units/ml. ml of collagenase I, as well as the method of explants. The following methods were used to remove fibroblasts: the use of the FibrOut™ system (CHI Scientific, USA), magnetic separation of fibroblasts using Anti-Fibroblast MicroBeads (Miltenyi Biotec, Germany), and cold trypsinization.Results. We have obtained 15 primary lung cancer cell cultures that have passed the zero order passage. In this work, the method of enzymatic dissociation turned out to be the most effective. Incubation of lung tumor samples with collagenase for 1 hour preserves the viability and adhesiveness of the cells. The explant method did not show its effectiveness for long-term cultivation, there was no migration of tumor cells to plastic. Magnetic separation, as a method of removing stromal components of fibroblasts, showed the greatest efficiency, while maintaining the viability of tumor cells.Conclusion. The obtained primary cell cultures of lung cancer can be used for many tasks of experimental oncology: studies of the biological characteristics of lung cancer, development of preclinical models for the studies on new chemotherapeutic drugs.
- 21 November 2022
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 3 (4) , 14-25
Open AccessPractical experience of a lung cancer primary cell culture collection creation at the National Medical Research Centre for Oncology
Purpose of the study. Testing of new chemotherapeutic agents in translational and biology medicine needs studies on immortalized cell lines. However, such models do not always have the biological properties of a tumor in situ, in contrast to primary cell cultures. Primary cultures of lung cancer cells have biological, morphological and molecular characteristics close or identical to tumor cells in vivo. Obtaining collections of primary lung cancer cell lines is an important task in creating various models for preclinical studies.Materials and methods. The materials are represented by postoperative tumor samples obtained from 25 patients with newly diagnosed lung cancer without prior treatment. The following methods were used to obtain primary cultures: enzymatic dissociation in Hanks' solution with the addition of 300 units/ml collagenase I (Thermo Fisher Scientific, USA), enzymatic dissociation using the Brain Tumor Dissoсiation Kit (Miltenyi Biotec, Germany) and 150 units/ml. ml of collagenase I, as well as the method of explants. The following methods were used to remove fibroblasts: the use of the FibrOut™ system (CHI Scientific, USA), magnetic separation of fibroblasts using Anti-Fibroblast MicroBeads (Miltenyi Biotec, Germany), and cold trypsinization.Results. We have obtained 15 primary lung cancer cell cultures that have passed the zero order passage. In this work, the method of enzymatic dissociation turned out to be the most effective. Incubation of lung tumor samples with collagenase for 1 hour preserves the viability and adhesiveness of the cells. The explant method did not show its effectiveness for long-term cultivation, there was no migration of tumor cells to plastic. Magnetic separation, as a method of removing stromal components of fibroblasts, showed the greatest efficiency, while maintaining the viability of tumor cells.Conclusion. The obtained primary cell cultures of lung cancer can be used for many tasks of experimental oncology: studies of the biological characteristics of lung cancer, development of preclinical models for the studies on new chemotherapeutic drugs.